Research & Development: Page 32

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Finding Patients With Rare Diseases — Two Truths and a Lie

    The hope for many companies developing drugs for rare diseases is this: the significant unmet need, given a dearth of treatment options, will drive demand and thus product uptake. Unfortunately, the reality is more challenging. While we have seen a significant increase in the number of drugs for ...

    By Susan Abedi • Feb. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D INFLUENCER: Bert Hartog, Ph.D. — Janssen Pharmaceutical Companies of Johnson & Johnson

    Unlocking clinical Bottlenecks We need to make more trials more accessible to more people. participate Bert Hartog, Ph.D., senior director at Janssen Clinical Innovation, Janssen Research & Development LLC is driven to eliminate the challenges preventing patients from participating in clinica...

    By Bert Hartog • Feb. 1, 2020
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D INFLUENCER: Jill Johnston — WCG, Clinical Services Organization

    Breaking Down the Roadblocks to Site Activation My focus is on getting life-saving drugs to patients as quickly as possible by reducing the time it takes sites to enroll patients into trials. There’s a big difference between people with a vision and those who can execute on that idea. Jill Johnst...

    By Jill Johnston • Feb. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Commanders & Chiefs: Innovators

    Chief innovators provide their insights on what innovation means to them, keys to driving innovation, and what it takes to foster an innovation-driven company culture. Defining Innovation Garde. We define innovation as breaking business barriers through measurable and unique client-focused soluti...

    By PharmaVoice Team • Feb. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The Road Ahead As we head into 2020, closing out a decade punctuated by an ever-changing healthcare dynamic shaped by scientific discoveries, technological breakthroughs, innovation at every level, as well as global geopolitical forces, there is no doubt that the status quo is no longer a busines...

    By Taren Grom • Jan. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Fish Skin for Wounds Fertram Sigurjonsson, Founder and CEO of Kerecis, talks about his company’s skin-substitution technology, which comes from Icelandic cod. Fertram Sigurjonsson started Kerecis because he wanted to help people avoid life-altering amputations, which often result from hard-to-hea...

    By Fertram Sigurjonsson • Jan. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Creating an Innovative Culture Fabrice Chouraqui, former president of Novartis Pharmaceuticals US, discusses his vision for creating an organization that is fueled by innovation. PV: How do you define innovation and what was your vision for reshaping of the pharmaceutical division of Novartis in ...

    By Fabrice Chouraqui • Jan. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Small Pharma Driving Big Pharma Innovation

    The Path to R&D Innovation Lies in the Power of Small Pharma Visionary thought leaders such as Bernard Munos of InnoThink and the Milken Institute and Paul Stoffels, M.D., vice chairman of the executive committee and chief scientific officer, Johnson & Johnson, have been advocating for ye...

    By Robin Robinson • Jan. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What Do Patients Want From Virtual Trials?

    How to plan for a successful patient-centric virtual trial Virtual and hybrid clinical trials, which require few or no visits to a trial site, have arrived as part of the new frontier of innovative, patient-centric research models. Through telemedicine, online patient portals, and connected devic...

    By Josh Rose • Jan. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Imagining what’s next… By 2020, it’s estimated that 1.7 megabytes of data will be created every second for every person on earth; 90% of the world’s data has been created in the last two years; healthcare data is doubling every 18 months; 5 billion people around the world lack access to surgeons;...

    By Taren Grom • Nov. 19, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    Novartis and Microsoft Collaborate on AI Lab Trend Watch: AI Partnerships and New Therapeutic Candidates Novartis has founded the Novartis AI innovation lab and is collaborating with Microsoft on the effort. The new lab aims to bolster Novartis AI capabilities from research through commercializat...

    By PharmaVoice Team • Nov. 19, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Remaking Clinical Trials with the Patient in Mind Tammy Guld, Global Team Lead for Janssen Clinical Innovation, talks about how the clinical trial experience for patients can be improved. PV: How can pharma companies improve the clinical trial experience for patients and get medicines to market f...

    By Tammy Guld • Nov. 19, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Year Ahead…

    We ask more than 130 experts, what needs to happen to address inefficiency and productivity to achieve aspirational goals for healthcare in the future. For this year’s special 2020 Year in Preview issue, we posed 20 provocative questions to our community of thought leaders, who represent all aspe...

    By Taren Grom • Nov. 19, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Dr. Robot

    Robots and docs — automation and clinician. In Disney’s animated hit Big Hero 6, we got a glimpse of what a future of a robot-enabled healthcare future might look like. Disney’s Baymax is an inflatable robot whose sole purpose is to take care of people in everyday life. But real-life medical robo...

    By Taren Grom • Nov. 19, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Bringing Humanity Back to Healthcare

    Technology can seem impersonal, but it can also be the driver for enabling more personal connections with patients. From the development of medicines by pharma companies to advancements in treatment protocols to using data to better apply therapeutic regimens, the healthcare industry is committed...

    By Kim Ribbink • Nov. 19, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Creating a Culture of Innovation

    To create a culture of innovation, pharma companies will need to encourage different ways of thinking. By definition, innovation is “a new idea, creative thoughts, new imaginations in form of device or method." Innovation is also viewed as the application of better solutions that meet new require...

    By Taren Grom • Nov. 19, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Detecting cancer early is the key to defeating it. Laboratory for Advanced Medicine (LAM) is working to detect cancer in its infancy when treatment options have the best chance to be successful. The company’s platform technology, IvyGene, detects the presence of cancer in blood samples and gives ...

    By PharmaVoice Team • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    First Patient Begins CVS Trial With Home Dialysis Machine Trend Watch: Telehealth Developments: At-home dialysis; skin patches for melanoma treatment; sweat monitoring, and norovirus detection. In August, the first patient involved in a clinical trial for a new CVS-funded home hemodialysis machin...

    By PharmaVoice Team • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    MIT Model Predicts Cognitive Decline Due to Alzheimer’s Trend Watch: From Precision Medicine to Precision Diagnosis, AI Provides More Exact Approach A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline d...

    By PharmaVoice Team • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Transitioning Emerging Companies into Commercial Powerhouses Ronald Andrews, President and CEO of OncoCyte and a serial entrepreneur with nearly 30 years of experience, shares lessons for fostering the growth of development-stage companies. PV: You joined OncoCyte as president and CEO in July 201...

    By Ronald Andrews • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma's Future in Virtual Healthcare

    With virtual health transforming the entire healthcare landscape, pharma is leveraging digital health tools to improve its processes. As healthcare is swept up in the extensive development of health management apps, telemedicine platforms, AI diagnosis, and the use of video, mobile apps, text mes...

    By Robin Robinson • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE: Artificial Intelligence: Artificial Intelligence Gains Ground Across Healthcare

    Adoption of artificial intelligence is accelerating across the healthcare industry. According to a survey of 50 executives at healthcare companies currently using AI, half believe AI will be broadly adopted across the industry by 2025. However, nearly half of U.S. companies say there is a need fo...

    By PharmaVoice Team • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Role of AI in Helping Clinicians Diagnose Patients

    I once thought I had multiple sclerosis. Actually, I may still have multiple sclerosis. I really don’t know for sure. A few months ago, a series of MS disease-awareness pop-ups began showing up on my web browser. They captured my attention because for a while I’d been experiencing a mix of health...

    By Susan Abedi • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Staying Ahead of the AI Curve in Commercial Pharma

    The commercial model within life sciences is ripe for change. In a landscape with harder to reach healthcare providers (HCPs) who are faced with more marketing noise than ever, the need for improved engagement is significant. According to DRG Digital, only 12% of HCPs said they had emailed with t...

    By Matthew Van Wingerden • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Role Artificial Intelligence Plays in Humanizing the Health Experience

    It used to be a broad, one-size-fits-all remedy for common complaints. If you needed it, there was little choice in what kind you received. If you didn’t need it, someone was ready to convince you otherwise. Fine-tuning it for an individual need was so cost-prohibitive the idea was basically scie...

    By David Geisinger • Oct. 1, 2019